xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

731

Orlandi et al.

2391. Khalid AN, Mace J, Smith TL. Outcomes of sinus surgery in adults with cystic fibrosis. Otolaryngol Head Neck Surg . 2009;141(3):358-363. 2392. Savastano V, Bertin S, Vittori T, Tripodi C, Magliulo G. Evalu ation of chronic rhinosinusitis management using the SNOT 22 in adult cystic fibrosis patients. Eur Rev Med Pharmacol Sci . 2014;18(14):1985-1989. 2393. Khalfoun S, Tumin D, Ghossein M, Lind M, Hayes Jr D, Kirkby S. Improved lung function after sinus surgery in cystic fibrosis patients with moderate obstruction. Otolaryngol Head NeckSurg . 2018;158(2):381-385. 2394. Kanjanaumporn J, Hwang PH. Effect of endoscopic sinus surgery on bronchiectasis patients with chronic rhinosinusi tis. Am J Rhinol Allergy . 2018;32(5):432-439. 2395. Leung M-K, Rachakonda L, Weill D, Hwang PH. Effects of sinus surgery on lung transplantation outcomes in cystic fibro sis. AmJRhinol . 2008;22(2):192-196. 2396. Rosbe KW, Jones DT, Rahbar R, Lahiri T, Auerbach AD. Endoscopic sinus surgery in cystic fibrosis: do patients bene fit from surgery? Int J Pediatr Otorhinolaryngol . 2001;61(2):113 119. 2397. Zheng Z, Safi C, Gudis DA. Surgical management of chronic rhinosinusitis in cystic fibrosis. Med Sci (Basel) . 2019;7(4). 2398. Virgin FW, Rowe SM, Wade MB, et al. Extensive surgical and comprehensive postoperative medical management for cystic fibrosis chronic rhinosinusitis. Am J Rhinol Allergy . 2012;26(1):70-75. 2399. Cannady SB, Batra PS, Koening C, et al. Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases. Laryngoscope . 2009;119(4):757-761. 2400. Kohanski MA, Reh DD. Chapter 11: granulomatous diseases and chronic sinusitis. Am J Rhinol Allergy . 2013;27(Suppl 1):S39-41. 2401. Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl JMed . 2017;376(20):1921-1932. 2402. Gulati S, Krossnes B, Olofsson J, Danielsen A. Sinonasal involvement in sarcoidosis: a report of seven cases and review of literature. Eur Arch Otorhinolaryngol . 2012;269(3):891 896. 2403. Mrowka-Kata K, Kata D, Lange D, Namyslowski G, Czecior E, Banert K. Sarcoidosis and its otolaryngological implications. Eur Arch Otorhinolaryngol . 2010;267(10):1507-1514. 2404. Braun JJ, Gentine A, Pauli G. Sinonasal sarcoidosis: review and report of fifteen cases. Laryngoscope . 2004;114(11):1960 1963. 2405. Srouji I, Lund V, Andrews P, Edwards C. Rhinologic symp toms and quality-of-life in patients with Churg-Strauss syn drome vasculitis. AmJRhinol . 2008;22(4):406-409. 2406. Aloulah M, Manes RP, Ng YH, et al. Sinonasal manifestations of sarcoidosis: a single institution experience with 38 cases. Int Forum Allergy Rhinol . 2013;3(7):567-72. 2407. Takeuchi K, Kitano M, Ishinaga H, et al. Recent advances in primary ciliary dyskinesia. Auris Nasus Larynx . 2016;43(3):229-236. 2408. Behan L, Dimitrov BD, Kuehni CE, et al. PICADAR: a diagnos tic predictive tool for primary ciliary dyskinesia. Eur Respir J . 2016;47(4):1103-1112.

2374. Karanth TK, Karanth V, Ward BK, Woodworth BA, Karanth L. Medical interventions for chronic rhinosinusitis in cystic fibrosis. Cochrane Database Syst Rev . 2019;10(10):Cd012979. 2375. Elkins MR, Robinson M, Rose BR, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. NEngl JMed 2006;354(3):229-240. 2376. Mainz JG, Schumacher U, Schädlich K, et al. Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis—results of a multicenter, prospective, randomized, double-blind, controlled trial. JCyst Fibros . 2016;15(6):e57-e66. 2377. Aanaes K, von Buchwald C, Hjuler T, Skov M, Alanin M, Johansen HK. The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cys tic fibrosis. Am J Rhinol Allergy . 2013;27(1):e1-e4. 2378. Moss RB, King VV. Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage: reduc tion in recurrence requiring surgery. Arch Otolaryngol Head NeckSurg . 1995;121(5):566-572. 2379. Jaffé A, Francis J, Rosenthal M, Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet . 1998;351(9100):420. 2380. Hadfield P, Rowe-Jones J, Mackay I. A prospective treatment trial of nasal polyps in adults with cystic fibrosis. Rhinology . 2000;38(2):63-65. 2381. Lowery AS, Gallant J-N, Woodworth BA, et al. Chronic rhino sinusitis treatment in children with cystic fibrosis: a cross sectional survey of pediatric pulmonologists and otolaryngol ogists. Int J Pediatr Otorhinolaryngol . 2019;124:139-142. 2382. Lindstrom DR, Conley SF, Splaingard ML, Gershan WM. Ibuprofen therapy and nasal polyposis in cystic fibrosis patients. J Otolaryngol . 2007;36(5). 2383. Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. Recom binant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci U S A . 1990;87(23):9188-9192. 2384. Sawicki GS, McKone EF, Pasta DJ, et al. Sustained benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data. Am J Respir Crit Care Med . . 2015;192(7):836-842. 2385. Elexacaftor/tezacaftor/ivacaftor (Trikafta) for cystic fibrosis. Med Lett Drugs Ther . 2020;62(1589):5-7. 2386. McCormick J, Cho DY, Lampkin B, et al. Ivacaftor improves rhinologic, psychologic, and sleep-related quality of life in G551D cystic fibrosis patients. Int Forum Allergy Rhinol . 2019;9(3):292-297. 2387. Middleton PG, Mall MA, Dřevínek P, et al. Elexacaftor– tezacaftor–ivacaftor for cystic fibrosis with a single Phe508del allele. NEngl JMed . 2019;381(19):1809-1819. 2388. Dilokthornsakul P, Hansen RN, Campbell JD. Forecasting US ivacaftor outcomes and cost in cystic fibrosis patients with the G551D mutation. Eur Respir J . 2016;47(6):1697-1705. 2389. Rickert S, Banuchi VE, Germana JD, Stewart MG, April MM. Cystic fibrosis and endoscopic sinus surgery: relationship between nasal polyposis and likelihood of revision endoscopic sinus surgery in patients with cystic fibrosis. Arch Otolaryngol Head Neck Surg . 2010;136(10):988-992. 2390. Tipirneni KE, Woodworth BA. Medical and surgical advance ments in the management of cystic fibrosis chronic rhinosi nusitis. Curr Otorhinolaryngol Rep . 2017;5(1):24-34.